openPR Logo
Press release

CURRENT TRENDS IN HEALTH TECHNOLOGY ASSESMENT

07-19-2016 06:41 PM CET | Health & Medicine

Press release from: SMi Group

SMi Group Reports: Quintiles, Alcon and Novartis to present their case studies on HTA at European Pharmaceutical Market Access, Pricing and Reimbursement (10 – 12 October 2016, Holiday Inn Kensington Forum, London, UK)

The 22nd annual conference will gather industry experts to discuss current challenges in European market access, pricing and reimbursement, capture on emerging market's regulatory framework to adapt your market access and P&R models, cancer drug funding, budget cuts and Accelerated Access Review in the UK, and much more.

SMi Group is proud to have Simone Breitkopf, Head HEOR, Governmental and Public Affairs, Alcon presenting on current trends in Health Technology Assessment (HTA). Simone will be discussing synergy between payers and European HTA bodies, current requirements for harmonisation of HTA and challenges associated with this. Furthermore she will focus on early dialogue for medical devices.

Janice Haigh, Practice Leader, Quintiles will be leading post - conference workshop entitled: Managing the global to local challenge. Audience will learn how to get all required information for HTA submission; and how to use HTA knowledge to drive drug usage at the desired price.

Post - conference workshop on HTA and reimbursement decisions for innovative medicines will be presented by Patrick Mollon, Former Director of Health Economic & Outcomes Research, Novartis; HEOR Director, PMHE2020.
For further information please visit: www.pharmaceuticalpricing.co.uk

KEYNOTE SPEAKERS IN 2016 INCLUDE:
- Ulf Staginnus, Head Market Access Oncology, Region Europe, Baxalta
- Gordon Spencer, Regional Market Access Lead EU & Canada, Shire International GmbH
- Alexander Natz, Secretary General, EUCOPE
- David Watson, Director of Pricing and PPRS, Association of the British Pharmaceutical Industry
- Panos Kefalas, Head of Health Economics and Market Access, Cell & Gene Therapy Catapult
- Ken Walsh, Senior Principal, Global Payer Strategy Consulting, Evidera
- Smita Sealey, UK Engagement Manager, Market Access, IMS Health
- Rasmus Jensen, Owner; Former Director and Head of Market Access, Drewes Jensen Consult; Lundbeck

For media enquiries please contact Anna Serazetdinova on +44 20 7827 6180 or aserazetdinova@smi-online.co.uk
For delegate enquiries contact Fateja Begum +44 (0) 20 7827 6184 or email fbegum@smi-online.co.uk
For sponsorship opportunities contact Alia Malick on +44 (0) 20 7827 6168 or email: amalick@smi-online.co.uk

---- END ----
About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

Ground & First Floor
1 Westminister Bridge Road
London, SE1 7XW

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release CURRENT TRENDS IN HEALTH TECHNOLOGY ASSESMENT here

News-ID: 350078 • Views:

More Releases from SMi Group

Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Conference
Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation. Industry leaders will uncover the
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual Highly Potent Active Pharmaceutical Ingredients Conference.
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK. With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast Conference in Boston, USA
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022. With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week. With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman. The

All 5 Releases


More Releases for HTA

Opportunities for the Global Medical Technology Evaluation Services Market to re …
The Medical Technology Evaluation Services Market : A thorough analysis of statistics about the current as well as emerging trends offers clarity regarding the Medical Technology Evaluation Services Market dynamics. The report includes Porter's Five Forces to analyze the prominence of various features such as the understanding of both the suppliers and customers, risks posed by various agents, the strength of competition, and promising emerging businesspersons to understand a valuable
Medical Technology Evaluation Services Market Global Forecast, Industry Trends, …
WMR has added the Global Medical Technology Evaluation Services Market Report to its database, providing a comprehensive evaluation of the factors shaping the market's growth trajectory. This research presents substantial data, serving as a valuable resource for industry professionals. It strikes an ideal balance by integrating qualitative and quantitative information about the market. Through a combination of quantitative statistics and qualitative analysis, it examines aspects such as market size, share,
Sodium Iodohippurate[131I] Injection Market Size, Share and Forecast By Key Play …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Sodium Iodohippurate[131I] Injection market is anticipated to grow at a compound annual growth rate (CAGR) of 16.9% between 2024 and 2031. The market is expected to grow to USD 14.09 Billion by 2024. The valuation is expected to reach USD 42.02 Billion by 2031. The Sodium Iodohippurate [131I] injection market is seeing steady growth due to its critical
Strontium-89 Chloride Injection Market Size, Share and Forecast By Key Players-Q …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Strontium-89 Chloride Injection market is anticipated to grow at a compound annual growth rate (CAGR) of 16.03% between 2024 and 2031. The market is expected to grow to USD 65.6 Billion by 2024. The valuation is expected to reach USD 185.74 Billion by 2031. The market for strontium-89 chloride injection is expanding significantly due to its growing application in the management of
New Trends of Health Technology Assessment (HTA) Services Market To Receive Over …
Growing Demand of the Health Technology Assessment (HTA) Services Market Overview 2024-2031: The latest release from Infinity Business Insights titled Health Technology Assessment (HTA) Services Market Research Report 2024-2031 (by Product Type, End-User / Application, and Regions / Countries) provides an in-depth assessment of the Health Technology Assessment (HTA) Services including key market trends, upcoming technologies, industry drivers, challenges, regulatory policies, key players company profiles, and strategies. Global Health Technology Assessment
Americium-241 Radioactive Source Market 2023 | Futuristic Trends- Eckert & Ziegl …
The Americium-241 Radioactive Source report compiles the market information depending upon market development and growth factors, optimizing the growth path. In addition, it highlights the strategies and market share of the leading vendors in the particular market. The report follows a robust research methodology model that helps to make informed decisions. It obtains both qualitative and quantitative market information supported by primary research. The Americium-241 Radioactive Source research report recognizes and